Asunto(s)
Hematoma , Humanos , Hematoma/etiología , Arteria Radial , Masculino , Músculos Pectorales/cirugía , FemeninoRESUMEN
Russell-Silver syndrome, also called asymmetric dwarf dysgenesis syndrome is an uncommon genetic disorder presenting with low birth weight, failure to thrive and growth retardation (short stature), developmental delay, facial dysmorphism and hemihypertrophy. The estimated incidence is between 1 case in 3,000 to 1 case in 100,000. We are hereby reporting one such case of postnatal growth retardation with facial dysmorphism and several other features of Russell-Silver syndrome and confirmed by genetic analysis.
RESUMEN
We present a case of left sided inferior vena cava with hemiazygous continuation draining into the coronary sinus via the left persistent superior vena cava. This was incidentally found in an individual referred to our centre for evaluation of palpitations. These caval anomalies are rare, and are often associated with no clinical manifestations. However, it is necessary to recognize them during routine workup to avoid diagnostic and procedural pitfalls.
Asunto(s)
Seno Coronario , Vena Cava Superior Izquierda Persistente , Humanos , Vena Cava Superior/anomalías , Vena Cava Inferior , DrenajeRESUMEN
We present a case of reversible left ventricular (LV) dysfunction with characteristic stress or "Takotsubo" cardiomyopathy (SCM) after therapeutic pericardiocentesis in a patient with tubercular pericardial effusion. SCM following pericardiocentesis is uncommon, as opposed to the well-defined entity, pericardial decompression syndrome (PDS). PDS is defined as a paradoxical deterioration of hemodynamics and development of severe biventricular dysfunction, cardiogenic shock, and pulmonary edema after uneventful, often large volume pericardiocentesis in patients of pericardial effusion.
Asunto(s)
Derrame Pericárdico , Cardiomiopatía de Takotsubo , Humanos , Pericardiocentesis , Cardiomiopatía de Takotsubo/diagnóstico , Cardiomiopatía de Takotsubo/etiología , Cardiomiopatía de Takotsubo/terapia , Derrame Pericárdico/diagnóstico por imagen , Derrame Pericárdico/etiología , Derrame Pericárdico/terapia , Síndrome , DescompresiónRESUMEN
OBJECTIVE: To compare the variation of feeding rate and time taken for feeds between manual and automated feeding via feed rail. METHODS: Stable preterm babies weighing between 1 and 2 kg, on partial or full enteral feeds via gavage were randomized into gravity and feed rail feeding group, respectively. Ten nurses and 4 babies were paired to form 40 nurse-baby pairs for the study. Forty feeding events in each groups were recorded. RESULTS: The median duration of feeding in the feed rail group was 18.5 min compared to 15 min in nurse-led feeding (p = 0.34). Feeding rate corrected for bodyweight ranged between 0.8 and 2.3 mL/kg/min in the feed rail group compared to 2.5 and 8.9 mL/kg/min in the control (manual gravity feed) group. This difference in the feed rate variation was statistically significant (p value of <0.0001). The median feed rate with feedrail was 1.3 mL/min as compared to 4.1 mL/min with manual gravity feeds. During the feed rail feeding, nurses were hands-free for 80% of the time. CONCLUSION: Feed rail feeding results in slow, sustained, and minimal variation in gravity feeding at a rate of 1 to 2 mL/kg/min without affecting the feeding duration compared to manual nurse-led feeding. TRIAL REGISTERED: Clinical Trials Registry India (CTRI/2020/06/025958).
Asunto(s)
Enterocolitis Necrotizante , Enfermedades del Prematuro , Nutrición Enteral , Humanos , Lactante , Recién Nacido de Bajo Peso , Recién Nacido , Recien Nacido PrematuroAsunto(s)
Betacoronavirus , Enfermedad de la Arteria Coronaria/terapia , Infecciones por Coronavirus/complicaciones , Intervención Coronaria Percutánea/métodos , Inhibidores de Agregación Plaquetaria/uso terapéutico , Neumonía Viral/complicaciones , Ensayos Clínicos Controlados Aleatorios como Asunto , COVID-19 , Enfermedad de la Arteria Coronaria/complicaciones , Enfermedad de la Arteria Coronaria/epidemiología , Infecciones por Coronavirus/epidemiología , Stents Liberadores de Fármacos , Salud Global , Humanos , Morbilidad/tendencias , Pandemias , Neumonía Viral/epidemiología , SARS-CoV-2 , Resultado del TratamientoAsunto(s)
Anomalías de los Vasos Coronarios/patología , Seno Aórtico/anomalías , Dolor en el Pecho/etiología , Angiografía por Tomografía Computarizada , Anomalías de los Vasos Coronarios/diagnóstico , Electrocardiografía , Humanos , Masculino , Persona de Mediana Edad , Seno Aórtico/diagnóstico por imagenRESUMEN
Atrial fibrillation (AF), the commonest arrhythmia in clinical practice, is also the commonest arrhythmia for which hospitalization is required. AF is associated with a 5 fold increase in stroke, a 2 fold increase in all-cause mortality, and a higher risk of heart failure. Hence, it is imperative to focus on the risk factors and clinical features of this condition, so that it can be prevented and managed in a timely manner. AF is linked with multiple metabolic and endocrine morbidities. This implies that the endocrinologist has an important role to play in AF detection and referral. This review, the first of a two part series, encourages preventive cardiovigilance, and especially electro-cardiovigilance, in diabetes practice.
Asunto(s)
Fibrilación Atrial/prevención & control , Diabetes Mellitus , Anticoagulantes/uso terapéutico , Fibrilación Atrial/complicaciones , Fibrilación Atrial/diagnóstico , Fibrilación Atrial/tratamiento farmacológico , Manejo de la Enfermedad , Electrocardiografía , Electrocardiografía Ambulatoria , Humanos , Accidente Cerebrovascular/etiología , Accidente Cerebrovascular/prevención & controlAsunto(s)
Oclusión Coronaria/complicaciones , Vasos Coronarios/diagnóstico por imagen , Electrocardiografía , Intervención Coronaria Percutánea/métodos , Infarto del Miocardio con Elevación del ST/diagnóstico , Angiografía Coronaria , Oclusión Coronaria/diagnóstico , Oclusión Coronaria/cirugía , Vasos Coronarios/cirugía , Humanos , Masculino , Persona de Mediana Edad , Infarto del Miocardio con Elevación del ST/etiología , Infarto del Miocardio con Elevación del ST/cirugíaAsunto(s)
Aneurisma Falso/complicaciones , Arteria Pulmonar/diagnóstico por imagen , Estenosis de Arteria Pulmonar/etiología , Accidentes de Tránsito , Adulto , Aneurisma Falso/diagnóstico por imagen , Aneurisma Falso/fisiopatología , Angiografía Coronaria , Humanos , Perdida de Seguimiento , Masculino , Estenosis de Arteria Pulmonar/diagnóstico por imagen , Estenosis de Arteria Pulmonar/fisiopatología , Factores de Tiempo , Negativa del Paciente al Tratamiento , Lesiones del Sistema Vascular/complicaciones , Lesiones del Sistema Vascular/diagnóstico por imagen , Lesiones del Sistema Vascular/fisiopatologíaAsunto(s)
Dolor en el Pecho/diagnóstico por imagen , Angiografía Coronaria , Electrocardiografía , Fibrinolíticos/uso terapéutico , Heparina/uso terapéutico , Infarto del Miocardio con Elevación del ST/diagnóstico por imagen , Dolor en el Pecho/tratamiento farmacológico , Dolor en el Pecho/etiología , Dolor en el Pecho/fisiopatología , Humanos , Masculino , Persona de Mediana Edad , Infarto del Miocardio con Elevación del ST/tratamiento farmacológico , Infarto del Miocardio con Elevación del ST/fisiopatología , Sudoración , Resultado del TratamientoRESUMEN
In selected patients, transcatheter closure of atrial septal defects with the AMPLATZER Septal Occluder has yielded excellent results. However, there is a slight risk of device embolization after deployment. We report the case of a 26-year-old woman in whom an embolized AMPLATZER device was retrieved percutaneously from the right pulmonary artery. We also discuss important technical principles for managing this uncommon but potentially severe complication.
Asunto(s)
Cateterismo Cardíaco/instrumentación , Remoción de Dispositivos/métodos , Embolia/terapia , Migración de Cuerpo Extraño/terapia , Defectos del Tabique Interatrial/terapia , Falla de Prótesis , Arteria Pulmonar , Dispositivo Oclusor Septal , Adulto , Cateterismo Cardíaco/efectos adversos , Embolia/diagnóstico , Embolia/etiología , Femenino , Migración de Cuerpo Extraño/diagnóstico , Migración de Cuerpo Extraño/etiología , Defectos del Tabique Interatrial/diagnóstico , Humanos , Diseño de Prótesis , Arteria Pulmonar/diagnóstico por imagen , Radiografía Intervencional , Resultado del TratamientoRESUMEN
BACKGROUND: Renal impairment in patients with coronary artery disease (CAD) is common and increases morbidity and mortality. Estimation of glomerular filtration rate (GFR) by measuring serum creatinine (Cr) or Cr clearance has limitations. Cystatin C is a novel marker for renal function that is very sensitive and specific for GFR estimation. The utility of plasma cystatin C (PCyC) in patients with CAD needs further study, especially in the developing world, where CAD is rising exponentially. METHODS AND RESULTS: In a prospective study of 150 patients undergoing coronary angiography, median PCyC was 1.45 mg/L; patients with levels ≥1.45 mg/L were older, had higher mean number of diseased coronary vessels, more frequently had triple vessel disease (TVD), and diffuse CAD on angiography. This association of higher PCyC levels with CAD remained robust even after excluding patients with eGFR<60 ml/min/1.73 m(2). The relative risk (RR) of having TVD or diffuse CAD in the overall cohort was 1.7 and 1.9, while it was 1.91 and 2.3 respectively in those with eGFR≥60 ml/min/1.73 m(2), with PCyC levels more than median. Categorization of the entire cohort and those with eGFR≥60, into tertiles based on 33rd and 66th percentiles of PCyC maintained the association of cystatin C with more severe CAD. CONCLUSION: In Indian patients with CAD, higher PCyC levels are associated with more severe CAD. The association of PCyC with severe CAD remains robust even in patients with normal or mildly impaired renal function. Cystatin C may have potential clinical usefulness as a marker for identification of high risk CAD patients.
Asunto(s)
Enfermedad Coronaria/sangre , Enfermedad Coronaria/diagnóstico por imagen , Cistatina C/sangre , Biomarcadores/sangre , Angiografía Coronaria , Femenino , Tasa de Filtración Glomerular , Humanos , India , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Población BlancaRESUMEN
Balloon atrial septostomy (BAS), which involves artificially creating a communication across the interatrial septum following trans-septal puncture and repetitive balloon dilatation, is known to be associated with therapeutic benefit in patients with severe pulmonary artery hypertension (PAH). Adult patients with large shunts and consequent severe PAH are not uncommon in the developing world, since they often seek medical attention late in the course of the disease. Often PAH in such cases is reversible with amelioration of symptoms after closure of the defect. We report a case of large atrial septal defect (ASD) with severe PAH who developed gross right heart failure following surgical closure of the ASD. A successful bail out BAS was performed using an Inoue balloon, avoiding the need for a redo surgery. The case highlights for the first time the use of Inoue balloon for performing a successful BAS.
RESUMEN
Coronary pseudoaneurysms following implantation of drug-eluting stents, although rare, are not unknown. Nearly all such cases have been reported in patients with sirolimus or paclitaxel polymer-based stents. We describe a case of coronary pseudoaneurysm developing with a non-polymer-based drug-eluting stent in a 50-year-old man who was successfully managed by coronary artery bypass grafting.
Asunto(s)
Aneurisma Falso/etiología , Angioplastia Coronaria con Balón/efectos adversos , Aneurisma Coronario/etiología , Enfermedad de la Arteria Coronaria/terapia , Stents Liberadores de Fármacos/efectos adversos , Aneurisma Falso/diagnóstico por imagen , Aneurisma Falso/cirugía , Angioplastia Coronaria con Balón/instrumentación , Fármacos Cardiovasculares/administración & dosificación , Aneurisma Coronario/diagnóstico por imagen , Aneurisma Coronario/cirugía , Angiografía Coronaria , Puente de Arteria Coronaria , Humanos , Masculino , Persona de Mediana Edad , Diseño de Prótesis , Sirolimus/administración & dosificación , Resultado del TratamientoRESUMEN
We report a case of cardiac tamponade caused by a coronary microleak from an unapparent site that was successfully managed by sealing of the pericardial space with intrapericardial injection of sterile synthetic glue which, to the best of our knowledge, is the first report of its kind for post-PCI coronary leaks.
Asunto(s)
Adhesivos/administración & dosificación , Angioplastia Coronaria con Balón/efectos adversos , Taponamiento Cardíaco/terapia , Estenosis Coronaria/terapia , Derrame Pericárdico/complicaciones , Pericardiocentesis/métodos , Taponamiento Cardíaco/diagnóstico , Taponamiento Cardíaco/etiología , Angiografía Coronaria , Estenosis Coronaria/diagnóstico por imagen , Femenino , Estudios de Seguimiento , Humanos , Inyecciones , Persona de Mediana Edad , Derrame Pericárdico/diagnóstico , Derrame Pericárdico/terapia , Pericardio , Prevención SecundariaRESUMEN
BACKGROUND: Cardiovascular (CV) dysfunction and cardiomyopathy can cause perioperative morbidity in pheochromocytoma patients, but have not been studied systematically. This prospective, case-control study evaluated nature and extent of CV dysfunctions and their reversal following curative pheochromocytoma surgery. METHODS: Thirty-five pheochromocytoma patients, 9 normotensive nonpheochromocytoma adrenal tumors and 10 essential hypertensives were evaluated with 2-dimensional echocardiography, tissue Doppler, and serum N-terminal pro-brain natriuretic peptide (s-NTpro-BNP, a sensitive myocardial damage biomarker) serially before and after treatment. RESULTS: Pheochromocytoma patients had systolic and diastolic dysfunction, reduced left ventricular (LV) ejection fraction (EF), increased LV end-diastolic and systolic dimensions and volumes, myocardial performance index, and decreased transmitral early/late velocity ratio, which were worse compared with controls. All indices improved significantly with α-blockade and after pheochromocytoma resection, and normalized over 3-6 months. Tissue Doppler early velocity was lower (P = .04) and s-NT-proBNP higher (P = .0001) in pheochromocytoma patients compared with controls. Seven pheochromocytoma patients (20%) had significant LV dysfunction (LVEF <45%; s-NTpro-BNP levels >500 pg/mL) and had more marked postoperative improvement. CONCLUSION: Global LV diastolic and systolic dysfunctions specific to pheochromocytoma are common and improve early postoperatively, with sustained improvement upon follow-up. Detailed cardiac evaluation with echocardiography, tissue Doppler, and s-NTpro-BNP may help to reduce perioperative morbidity and monitor recovery in pheochromocytoma patients.
Asunto(s)
Neoplasias de las Glándulas Suprarrenales/cirugía , Enfermedades Cardiovasculares/etiología , Feocromocitoma/cirugía , Adolescente , Neoplasias de las Glándulas Suprarrenales/complicaciones , Adulto , Anciano , Cardiomiopatías/sangre , Cardiomiopatías/diagnóstico por imagen , Cardiomiopatías/etiología , Enfermedades Cardiovasculares/sangre , Enfermedades Cardiovasculares/diagnóstico por imagen , Estudios de Casos y Controles , Niño , Ecocardiografía , Femenino , Humanos , Hipertensión/sangre , Hipertensión/etiología , Masculino , Persona de Mediana Edad , Feocromocitoma/complicaciones , Estudios Prospectivos , Distribución por Sexo , Resultado del Tratamiento , Adulto JovenRESUMEN
Coronary venous spasm is an under-recognized and often reversible technical challenge that may be encountered while placing bi-ventricular pacing devices. We describe a case of severe vasopsam in the posterolateral left ventricular vein that was managed by balloon angioplasty, followed by successful placement of the left ventricular lead.
Asunto(s)
Angioplastia de Balón/métodos , Angioplastia/métodos , Terapia de Resincronización Cardíaca/efectos adversos , Vasos Coronarios , Espasmo/etiología , Espasmo/terapia , Dispositivos de Terapia de Resincronización Cardíaca/efectos adversos , Cardiomiopatía Dilatada/terapia , Vasoespasmo Coronario/etiología , Vasoespasmo Coronario/terapia , Insuficiencia Cardíaca/terapia , Humanos , Masculino , Persona de Mediana Edad , Resultado del Tratamiento , VenasRESUMEN
All three coronary arteries originating from a single coronary ostium is a rarity. Single coronary artery (CA) arising from the left aortic sinus is far more uncommon than one arising from the right sinus. Usually in such cases, the right coronary artery (RCA) arises as a distal continuation of the left circumflex artery. We describe an extremely uncommon anatomic variant, where the RCA arose from the single undivided CA as a branch of the left main coronary artery and followed a retro-aortic course before reaching its designated anatomic territory.